Lornoxicam 8 mg 1 ampoule
Global napi pharmaceuticals
Global Pharmaceutical Industries (GPI)
Composition
• Active ingredient
Lornoxicam 8 mg.
Lornoxicam 8 mg is a nonsteroidal anti-inflammatory drug (NSAID) intended for injection. It is used to relieve pain and inflammation in both acute and chronic conditions.
Pharmacological properties
Lornoxicam belongs to the oxicam class. It has strong analgesic, anti-inflammatory, and antipyretic effects. Its mechanism of action is based on the inhibition of prostaglandin synthesis through the blockade of the cyclooxygenase (COX) enzyme.
Indications for use
• Acute pain of various origins
• Post-traumatic or postoperative pain
• Arthritis, arthrosis, osteoarthritis
• Rheumatic diseases
• Radiculopathy, lumbago, sciatica.
Dosage and administration
• Administered intramuscularly (IM) or intravenously (IV)
• Single dose: 8 mg, adjustable as prescribed by a physician
• Frequency and duration of administration depend on the clinical situation
• The lyophilized powder should be dissolved in the provided solvent (2 ml) before use.
Dosage form
Lyophilized powder in a vial + ampoule with solvent (2 ml).